1Nickoloff BJ. The immunologic and genetic basis of psoriasis. Arch Dermatol 1999; 135:1104- 1110.
2Kaur L, Kumar B. Psoriasis- an overview.Drugs Bull 1998;22:29-49.
3Krueger JG. The immunologic basis for the treatment of psoriasis with new biologic agent.J Am Acad Dermatol 2002 ;46:1 - 23.
4Gottlieb A, Krueger JG, Bright R, et al. Effects of administration of a single dose of humanized monoclonal antibody to CDlla on the immunobiology and clinical activity of psoriasis. J Am Acad Dermatol 2000; 42: 428-435.
5Gottlieb A, Miller B, Chaudhari U, et al.Clinical and histologic effect of subcutaneously administered anti - CDlla in patients with psoriasis. J Invest Dermatol 2000;114:840.
6Gottlieb A, Abdulghani A, Totoritis R, et al.Results of a single- dose, dose - escalating trial of anti- B7 monoclonal antibody (IDEC-114) in patients with psoriasis. J Invest Dennatol 2000; 114:546.
7Ravindra A, Nitika V. Biotherapy: a novel approach in the treatment of psoriasis. Drugs of the Fut:Lre 2002;27:1071 - 1077.
8Krueger JG, Waiters B, Miyazawa M, et al.Successful in vivo blockade of CD25 on T cells by administration of humanized anti - Tac antibody to patients with psoriasis. J Am Acad Dermatol 2000;43:448-458.
9Asadullah K, Friedrich M, Hanneken S, et al. Effects of systemic interleukin - 10 therapy on psoriatic skin lision: histologic, immunohistologic and molecular biology findings. J Invest Dermatol 2001 ; 116:721 - 727.
10Duan H, Koga T, Kohda F, et al. Interleukin- 8 positive neutrophils in psoriasis. J Deamatol Sci 2001;26:119.
2Sigmundsdottir H Johnsfon A,Gudjonsson JE,etal.NarrowbanduvB irradiation Tcells.Arch Dermatol Res,2004,295:509-516.
3Abraham S,Lehmann B,Knuschke P,etal.UVB-induced conversion of T-dehydro cholesterol to lalpa,25-dihydsoxyvitamin D(calcitriol) in cul-tured Keratinocytes in upregulated by tumor necrosis factor alpha[J].Exp Dermatol,2005,14:154.
4Piski G,Tursen u,Sylva-stfeenland RM,etal clinical improvement in chronic plague-type psoriasis esions after narrow-land UVB therapy is a wompanied by a decrease in the expression of IFNgamma inducers-IL-12,IL-18 and IL-23[J].Exp Dermtol,2004,13:764-772.
5Sehrnitt J, Wozel G. The psoriasis area and severity index is theAdequate erlterlon to define severity in chronic plaque - type psoriasis. Dermatology,2005,210 : 194 -199.
8Lohner ME,Krueger JG,Gottlieb A,et al.Clinical trials of a fully human anti-IL-8 antibody for the treatment of psoriasis[J].Br J Dermatol,1999,141(5):989-992.
9Dawe RS, Wainwright N J, Cameron H, et al. Narrowband (TL-01) ultraviolet B phototherapy for chronic plaque psoriasis: three times or five times weekly treatment. Br J Dermatol 1998,138 : 833 - 839.
